vs
Side-by-side financial comparison of CB Financial Services, Inc. (CBFV) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
CB Financial Services, Inc. is the larger business by last-quarter revenue ($13.8M vs $13.2M, roughly 1.0× TriSalus Life Sciences, Inc.). On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 19.9%). CB Financial Services, Inc. produced more free cash flow last quarter ($17.2M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 1.2%).
CB Bank is one of Myanmar's largest commercial banks. It became the first bank in Myanmar to issue ATM cards and credit cards. The bank, led by U Khin Maung Aye (Chairman) and U Kyaw Thu Ko (CEO) has over 245 branches across the country.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
CBFV vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $13.8M | $13.2M |
| Net Profit | — | $-9.8M |
| Gross Margin | — | 86.7% |
| Operating Margin | 38.1% | -24.8% |
| Net Margin | — | -73.9% |
| Revenue YoY | 19.9% | 59.8% |
| Net Profit YoY | — | 3.5% |
| EPS (diluted) | $0.90 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $13.2M | ||
| Q3 25 | $2.4M | $11.6M | ||
| Q2 25 | $13.5M | $11.2M | ||
| Q1 25 | $12.1M | $9.2M | ||
| Q4 24 | $13.2M | $8.3M | ||
| Q3 24 | $12.7M | $7.3M | ||
| Q2 24 | $12.2M | $7.4M | ||
| Q1 24 | $13.5M | $6.5M |
| Q4 25 | — | $-9.8M | ||
| Q3 25 | $-5.7M | $-10.8M | ||
| Q2 25 | $3.9M | $-8.3M | ||
| Q1 25 | $1.9M | $-10.4M | ||
| Q4 24 | — | $-10.1M | ||
| Q3 24 | $3.2M | $-2.4M | ||
| Q2 24 | $2.6M | $-4.3M | ||
| Q1 24 | $4.2M | $-13.2M |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
| Q4 25 | 38.1% | -24.8% | ||
| Q3 25 | -289.8% | -77.9% | ||
| Q2 25 | 35.0% | -65.4% | ||
| Q1 25 | 19.3% | -79.9% | ||
| Q4 24 | 23.1% | -91.8% | ||
| Q3 24 | 31.2% | -118.9% | ||
| Q2 24 | 26.4% | -111.0% | ||
| Q1 24 | 37.9% | -180.8% |
| Q4 25 | — | -73.9% | ||
| Q3 25 | -235.2% | -93.5% | ||
| Q2 25 | 29.3% | -73.9% | ||
| Q1 25 | 15.8% | -113.2% | ||
| Q4 24 | — | -122.4% | ||
| Q3 24 | 25.3% | -32.6% | ||
| Q2 24 | 21.8% | -58.8% | ||
| Q1 24 | 31.1% | -204.5% |
| Q4 25 | $0.90 | $-0.22 | ||
| Q3 25 | $-1.07 | $-0.96 | ||
| Q2 25 | $0.74 | $-0.27 | ||
| Q1 25 | $0.35 | $-0.39 | ||
| Q4 24 | $0.45 | $-0.38 | ||
| Q3 24 | $0.60 | $-0.12 | ||
| Q2 24 | $0.51 | $-0.21 | ||
| Q1 24 | $0.82 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $157.5M | $-33.9M |
| Total Assets | $1.5B | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $20.4M | ||
| Q3 25 | $55.9M | $22.7M | ||
| Q2 25 | $64.5M | $26.5M | ||
| Q1 25 | $61.3M | $13.0M | ||
| Q4 24 | $49.6M | $8.5M | ||
| Q3 24 | $147.3M | $11.3M | ||
| Q2 24 | $142.6M | $16.5M | ||
| Q1 24 | $73.7M | $4.0M |
| Q4 25 | $157.5M | $-33.9M | ||
| Q3 25 | $152.5M | $-26.7M | ||
| Q2 25 | $148.4M | $-19.4M | ||
| Q1 25 | $148.3M | $-34.4M | ||
| Q4 24 | $147.4M | $-25.9M | ||
| Q3 24 | $149.1M | $-20.4M | ||
| Q2 24 | $142.9M | $-25.3M | ||
| Q1 24 | $141.6M | $-36.0M |
| Q4 25 | $1.5B | $35.3M | ||
| Q3 25 | $1.5B | $36.5M | ||
| Q2 25 | $1.5B | $41.3M | ||
| Q1 25 | $1.5B | $28.6M | ||
| Q4 24 | $1.5B | $24.0M | ||
| Q3 24 | $1.6B | $27.5M | ||
| Q2 24 | $1.6B | $32.4M | ||
| Q1 24 | $1.5B | $17.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $17.8M | $-2.5M |
| Free Cash FlowOCF − Capex | $17.2M | $-2.5M |
| FCF MarginFCF / Revenue | 124.1% | -19.1% |
| Capex IntensityCapex / Revenue | 4.7% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.5M | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $17.8M | $-2.5M | ||
| Q3 25 | $4.6M | $-3.7M | ||
| Q2 25 | $4.1M | $-7.3M | ||
| Q1 25 | $4.0M | $-4.5M | ||
| Q4 24 | $6.8M | $-5.7M | ||
| Q3 24 | $3.1M | $-10.8M | ||
| Q2 24 | $-1.2M | $-13.4M | ||
| Q1 24 | $3.3M | $-10.9M |
| Q4 25 | $17.2M | $-2.5M | ||
| Q3 25 | $4.5M | $-3.9M | ||
| Q2 25 | $3.9M | $-7.4M | ||
| Q1 25 | $3.9M | $-5.3M | ||
| Q4 24 | $3.4M | $-5.8M | ||
| Q3 24 | $2.2M | $-11.0M | ||
| Q2 24 | $-2.4M | $-13.5M | ||
| Q1 24 | $2.3M | $-10.9M |
| Q4 25 | 124.1% | -19.1% | ||
| Q3 25 | 186.5% | -33.9% | ||
| Q2 25 | 28.8% | -66.1% | ||
| Q1 25 | 32.5% | -57.3% | ||
| Q4 24 | 26.0% | -69.7% | ||
| Q3 24 | 17.4% | -149.9% | ||
| Q2 24 | -19.6% | -183.1% | ||
| Q1 24 | 17.0% | -169.3% |
| Q4 25 | 4.7% | 0.3% | ||
| Q3 25 | 4.3% | 1.9% | ||
| Q2 25 | 1.9% | 0.8% | ||
| Q1 25 | 0.8% | 8.2% | ||
| Q4 24 | 25.1% | 0.6% | ||
| Q3 24 | 6.7% | 2.3% | ||
| Q2 24 | 10.0% | 0.8% | ||
| Q1 24 | 7.2% | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.05× | — | ||
| Q1 25 | 2.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | -0.44× | — | ||
| Q1 24 | 0.78× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.